Clinical Trial Update: PEG-Asparaginase Associated Pancreatitis, Hepatotoxicity and Hyperlipidemia in Children With ALL

View source ↗

Summary

Clinical trial update notes pancreatitis, hepatotoxicity and hyperlipidemia associated with PEG-asparaginase in children with acute lymphoblastic leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Pancreatitis

Drugs mentioned

• Pegaspargase (pegaspargase)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Acute Lymphoblastic Leukemia, Pancreatitis | Status: COMPLETED